Does AMIODARONE Cause Interstitial lung disease? 1,421 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 1,421 reports of Interstitial lung disease have been filed in association with AMIODARONE (Amiodarone Hydrochloride). This represents 5.7% of all adverse event reports for AMIODARONE.
1,421
Reports of Interstitial lung disease with AMIODARONE
5.7%
of all AMIODARONE reports
388
Deaths
939
Hospitalizations
How Dangerous Is Interstitial lung disease From AMIODARONE?
Of the 1,421 reports, 388 (27.3%) resulted in death, 939 (66.1%) required hospitalization, and 208 (14.6%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMIODARONE. However, 1,421 reports have been filed with the FAERS database.
What Other Side Effects Does AMIODARONE Cause?
Drug ineffective (2,223)
Dyspnoea (2,182)
Off label use (1,608)
Drug interaction (1,589)
Asthenia (1,452)
Hyperthyroidism (1,410)
Fatigue (1,269)
Bradycardia (1,261)
Atrial fibrillation (1,211)
Hypotension (1,090)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
TOCILIZUMAB (1,229)
Which AMIODARONE Alternatives Have Lower Interstitial lung disease Risk?
AMIODARONE vs AMISULPRIDE
AMIODARONE vs AMITRIPTYLINE
AMIODARONE vs AMITRIPTYLINE\PERPHENAZINE
AMIODARONE vs AMIVANTAMAB
AMIODARONE vs AMIVANTAMAB-VMJW